Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Saved in:
| Title: | Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell. |
|---|---|
| Authors: | Gao Y; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Souza-Fonseca-Guimaraes F; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia., Bald T; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Ng SS; Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Natural Sciences, Griffith University, Nathan, Queensland, Australia., Young A; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Ngiow SF; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Rautela J; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia., Straube J; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Waddell N; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Blake SJ; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Yan J; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Bartholin L; Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France., Lee JS; Control of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Vivier E; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France., Takeda K; Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan., Messaoudene M; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.; Gustave Roussy Cancer Campus, Villejuif, France., Zitvogel L; Gustave Roussy Cancer Campus, Villejuif, France.; University Paris-Saclay, Kremlin Bicêtre, Paris, France.; CIC1428, Gustave Roussy Cancer Campus, Villejuif, France., Teng MWL; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Belz GT; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia., Engwerda CR; Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Huntington ND; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia., Nakamura K; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Hölzel M; Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany., Smyth MJ; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.; School of Medicine, The University of Queensland, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au. |
| Source: | Nature immunology [Nat Immunol] 2024 May; Vol. 25 (5), pp. 925-926. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38514890 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gao+Y%22">Gao Y</searchLink>; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Souza-Fonseca-Guimaraes+F%22">Souza-Fonseca-Guimaraes F</searchLink>; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Bald+T%22">Bald T</searchLink>; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Ng+SS%22">Ng SS</searchLink>; Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Natural Sciences, Griffith University, Nathan, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Young+A%22">Young A</searchLink>; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Ngiow+SF%22">Ngiow SF</searchLink>; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Rautela+J%22">Rautela J</searchLink>; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Straube+J%22">Straube J</searchLink>; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Waddell+N%22">Waddell N</searchLink>; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Blake+SJ%22">Blake SJ</searchLink>; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Yan+J%22">Yan J</searchLink>; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Bartholin+L%22">Bartholin L</searchLink>; Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Control of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Vivier+E%22">Vivier E</searchLink>; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Takeda+K%22">Takeda K</searchLink>; Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Messaoudene+M%22">Messaoudene M</searchLink>; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.; Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Zitvogel+L%22">Zitvogel L</searchLink>; Gustave Roussy Cancer Campus, Villejuif, France.; University Paris-Saclay, Kremlin Bicêtre, Paris, France.; CIC1428, Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Teng+MWL%22">Teng MWL</searchLink>; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Belz+GT%22">Belz GT</searchLink>; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Engwerda+CR%22">Engwerda CR</searchLink>; Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Huntington+ND%22">Huntington ND</searchLink>; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Nakamura+K%22">Nakamura K</searchLink>; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Hölzel+M%22">Hölzel M</searchLink>; Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Smyth+MJ%22">Smyth MJ</searchLink>; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.; School of Medicine, The University of Queensland, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100941354%22">Nature immunology</searchLink> [Nat Immunol] 2024 May; Vol. 25 (5), pp. 925-926. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Inc%22">Nature America Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100941354 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-2916 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215292908%22">15292908 </searchLink><i>NLM ISO Abbreviation: </i>Nat Immunol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38514890 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41590-024-01799-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 925 Titles: – TitleFull: Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gao Y – PersonEntity: Name: NameFull: Souza-Fonseca-Guimaraes F – PersonEntity: Name: NameFull: Bald T – PersonEntity: Name: NameFull: Ng SS – PersonEntity: Name: NameFull: Young A – PersonEntity: Name: NameFull: Ngiow SF – PersonEntity: Name: NameFull: Rautela J – PersonEntity: Name: NameFull: Straube J – PersonEntity: Name: NameFull: Waddell N – PersonEntity: Name: NameFull: Blake SJ – PersonEntity: Name: NameFull: Yan J – PersonEntity: Name: NameFull: Bartholin L – PersonEntity: Name: NameFull: Lee JS – PersonEntity: Name: NameFull: Vivier E – PersonEntity: Name: NameFull: Takeda K – PersonEntity: Name: NameFull: Messaoudene M – PersonEntity: Name: NameFull: Zitvogel L – PersonEntity: Name: NameFull: Teng MWL – PersonEntity: Name: NameFull: Belz GT – PersonEntity: Name: NameFull: Engwerda CR – PersonEntity: Name: NameFull: Huntington ND – PersonEntity: Name: NameFull: Nakamura K – PersonEntity: Name: NameFull: Hölzel M – PersonEntity: Name: NameFull: Smyth MJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2024 May Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1529-2916 Numbering: – Type: volume Value: 25 – Type: issue Value: 5 Titles: – TitleFull: Nature immunology Type: main |
| ResultId | 1 |